Key takeaways from the TT Lifesciences PMSV & QARA Conference, exploring the connection between PMS and PMCF, the importance of meaningful lifecycle evidence, and how well-designed surveys can help close evidence gaps

As MedTech commercial models evolve beyond traditional equipment sales, customers are increasingly evaluating long-term partnerships rather than standalone products. This article explores how subscriptions, managed services and outcome-focused agreements are reshaping buying decisions and what suppliers must do to deliver value throughout the customer relationship.

How can research teams move more efficiently from data collection to actionable insights? In this co-authored article, Purdie Pascoe and Displayr explore how research expertise, technology and collaboration can streamline analysis, accelerate reporting and make insights more accessible through interactive dashboards and data visualisation.

Great research is only valuable if it drives action. Discover how better planning, stakeholder engagement and tailored deliverables can help insights resonate further across the business.

As we reach the midpoint of 2026, a clear picture is emerging from the conversations we've been having across the MedTech industry. While the topics may seem different on the surface, many are converging around a broader shift in how organisations think about evidence, insight, and the journey from innovation to real-world adoption. Rather than a set of trends or predictions, these are recurring themes we're seeing in practice and believe will continue to shape decision-making across the industry.

Many MedTech companies are rethinking the house of brands model as portfolios become more complex through platforms, digital ecosystems, and long-term partnerships. A stronger masterbrand can help scale trust across the portfolio, simplify complexity, and support adoption of new technologies and services.

In this webcast, our Precision Medicine and Diagnostics experts explore why true differentiation is often overlooked in real-world practice, and what diagnostic companies can do to ensure their tests and portfolios are clearly understood, valued and adopted.

 Behind every great research project is a system quietly keeping thousands of data points accurate, scalable, and insight ready. In this article, our Programming & Analytics experts explore how automation and innovation are transforming large-scale market research, freeing researchers to focus on what matters most: delivering meaningful insight.

In this webcast our specialists Sabera Hyderally, Head of US MedTech and Kristin Lovallo, Director, will share how this advanced methodology can uncover deeper insights, helping organizations prioritize product features, refine value propositions, and make more confident strategic decisions.

We are delighted to be attending the ACC Annual Conference from March 28–30 in New Orleans, Louisiana. Senior Research Executives Molly Hines and Supreet Kaur will be representing Purdie Pascoe at the event.

We are delighted to be attending the SAGES Annual Conference from March 25–28 in Tampa, Florida. Kristin Lovallo, US Research Director, will be representing Purdie Pascoe at the event.

Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.

As the ctDNA cancer monitoring market becomes increasingly competitive, established panels continue to maintain their foothold amidst a surge of new entrants. Purdie Pascoe is conducting an ongoing syndicated study exploring the US ctDNA Cancer Monitoring Landscape. Waves 1 through 4 are now available for immediate purchase.

Our primary market research team combines deep expertise with a full range of qualitative and quantitative techniques, including the latest digital approaches with a wealth of experience across medical devices, digital healthcare, drug delivery, precision medicine and diagnostics.

Innovation sits right at the intersection of data, technology, and research. Our Innovation team’s goal is simple: make complex studies easier to run, insights easier to find, and decisions easier to make, for both our research colleagues and our clients.

Have you ever wondered what really makes your employees tick when it comes to their health and wellbeing? What drives them to move, eat well, switch off mentally or what silently holds them back? Each November, millions join Movember to spark conversation and action around men’s physical and mental health. At Purdie Pascoe, we’ve taken part for the last few years. But this year, we wanted to go a step further. Instead of just looking outward, we turned the lens on ourselves.

As we all start to get into the festive spirit ahead of the holiday season, it’s a perfect time to reflect on achievements, and of course challenges across the past year. 2025 has been a big year for Purdie Pascoe, and in this short interview, Co-Founder Guy Pascoe provides insight into what has made this year so pivotal for the business.

Beneath the white coats, doctors are still human. They respond to good stories, authentic visuals, and messages that feel credible and relevant.  At Purdie Pascoe, ad testing continues to be one of the most revealing parts of our work, helping medical device manufacturers understand not just what their audiences say they want, but what they actually respond to.

Sabera Hyderally, Purdie Pascoe’s Head of US MedTech, recently facilitated an engaging, honest, and thought-provoking conversation with experts from across the MedTech and Diagnostics industry. The discussion explored how MedTech differs from other sectors, particularly pharmaceuticals, and what these differences mean for how we approach market research, innovation, and patient engagement. 

With over 50 of us now based across the UK, US, and Europe, this year’s meeting was a true celebration of our growth, our people, and our commitment to MedTech. Fittingly, our theme this year was bold and simple: MedTech, as it’s not just one of our sectors - it’s our sole focus.